Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
PM & R : the Journal of Injury, Function, and Rehabilitation|November 24, 2012
Exercise to enhance neurocognitive function after traumatic brain injuryDavid Fogelman, Ross ZafonteInvestigational New Drugs|May 8, 2020
Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low C<sub>max</sub> and improved tolerability, in patients with solid tumorsJaffer A Ajani, Milind Javle, Cathy Eng, et al.Cancer Medicine|December 31, 2015
Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstructionJay Chouhan, Rohan Gupta, Joe Ensor, et al.Scientific Reports|August 10, 2019
Dual-Energy X-Ray Absorptiometry Compared to Computed Tomography for Visceral Adiposity Assessment Among Gastrointestinal and Pancreatic Cancer SurvivorsAdriana M Coletta, Ann H Klopp, David Fogelman, et al.Pancreas|November 27, 2014
Perfusion computed tomography as functional biomarker in randomized run-in study of bevacizumab and everolimus in well-differentiated neuroendocrine tumorsJames C Yao, Alexandria T Phan, Kenneth Hess, et al.Cancer|September 2, 2008
Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinomaMichael J Overman, Scott Kopetz, Sijin Wen, et al.JAMA Oncology|March 4, 2021
Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants: Findings From 2 Phase 2 Nonrandomized Clinical TrialsMilind Javle, Einat Shacham-Shmueli, Lianchun Xiao, et al.The Oncologist|December 30, 2017
Portomesenteric Venous Stenting for Palliation of Ascites and Variceal Bleeding Caused by Prehepatic Portal HypertensionRahul A Sheth, Sharjeel H Sabir, Philip Parmet, et al.Clinical Colorectal Cancer|September 17, 2008
Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 casesMichael J Overman, David Fogelman, Aref Al-Kali, et al.American Journal of Clinical Oncology|July 29, 2014
Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer: A Pooled Analysis of 4 Prospective Trials of Gemcitabine-based Therapy With BevacizumabShubham Pant, Ludmila K Martin, Susan Geyer, et al.Pageof 6